✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Rohto Pharmaceutical Co Ltd

Common Name
Rohto Pharmaceutical
Country
Japan
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
9,144
Ticker
4527
Exchange
Japan Exchange Group
Description
Rohto Pharmaceutical Co., Ltd. is a leading Japanese manufacturer specializing in pharmaceutical products, cosmetics, and functional foods. Founded in 1899 and headquartered in Osaka, the company is r...

Rohto Pharmaceutical's Climate Target Data Preview

As of 2024, Rohto Pharmaceutical has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Rohto Pharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target*
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
-30%a
2025
Absolute-based Target*
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
-46%a
2030
*. This target is limited in scope and does not represent the company's full operational or organizational boundaries
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/climate-targets?ticker=4527"

Verified Sources Behind Rohto Pharmaceutical’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Rohto Pharmaceutical's Integrated Report 2024

Insights into Rohto Pharmaceutical's Greenhouse Gas Emissions Pathways

As of 2024, Rohto Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a

Does Rohto Pharmaceutical have a target to reduce the emissions from its operations?

As of 2024, Rohto Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Rohto Pharmaceutical's most ambitious operational target is to reduce these emissions by 46% by 2030, compared to a baseline of 15,823.383 Metric Tonnes of CO2 equivalent (mtCO2e) in 2013.a

As of 2023, Rohto Pharmaceutical is lagging behind on its operational emissions reduction target, having achieved 42.61% of the planned reduction.a

Rohto Pharmaceutical's Operational (Scope 1+2) Emissions Pathway

201320232025203004 k8 k12 k16 kBaselineCurrent (-20%)Target 2030 (-46%)
Want Full Access to Rohto Pharmaceutical's Climate Targets Dataset?
Start 30-Day Free Trial